• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

treatment-resistant depression

Bicycle bike ride travel
Biotech

Cyclerion emerges from latest pivot as neuro biotech

When it comes to Cyclerion’s colorful backstory, the only consistency has been its inconsistency.
James Waldron Sep 24, 2025 4:15am
colorful brain art model

Beckley Psytech psychedelic reduces depression symptoms in ph. 2

Jul 1, 2025 8:30am
compass map direction find trail north

Compass' psychedelic therapy wins ph. 3, investors unimpressed

Jun 23, 2025 8:05am
forest woods paths paths diverge

Supernus depression drug candidate fails midstage trial

Feb 19, 2025 6:40am
compass map direction find trail north

Compass delays phase 3 psychedelic data, lays off 30% of staff

Oct 31, 2024 9:00am
brain amyloid alzheimers strings detailed web complicated thought

Abbott begins neuromodulation trial in drug-resistant depression

Sep 4, 2024 11:02am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings